Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Women are more prone to certain diseases, such as osteoporosis, osteoarthritis, anemia, menstruation-related disorders, depression, and obesity. Hence, increase in incidence of these conditions is likely to boost the market in the coming years.
The global Womens Health market size is expected to reach US$ 44780 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Womens Health in various end use industries. The expanding demands from the Hospitals, Clinics and Others,, are propelling Womens Health market. Postmenopausal Osteoporosis, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Endometriosis segment is estimated at % CAGR for the next seven-year period.
Government and various private organizations are working toward improving women’s health across the world, and this is likely to drive growth in the coming years. Reimbursement coverage provided to women is also a key factor driving the market in developed countries. For instance, various coverage plans in the U.S. provide preventive services for women without charging any copayment. These include screening for anemia, hepatitis B, & breast cancer on a routine basis, folic acid supplements for women who are likely to be pregnant, and contraceptive methods, among others.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Womens Health, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Womens Health market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Womens Health market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Womens Health sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Womens Health covered in this report include Allergan, Bayer, Merck, Pfizer, Teva Pharmaceutical, Agile Therapeutics, Amgen, Apothecus Pharmaceutical and AstraZeneca, etc.
The global Womens Health market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Global Womens Health market, by region:
Global Womens Health market, Segment by Type:
Global Womens Health market, by Application
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Womens Health companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index
1 Market Overview of Womens Health
1.1 Womens Health Market Overview
1.1.1 Womens Health Product Scope
1.1.2 Womens Health Market Status and Outlook
1.2 Global Womens Health Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Womens Health Market Size by Region (2018-2029)
1.4 Global Womens Health Historic Market Size by Region (2018-2023)
1.5 Global Womens Health Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Womens Health Market Size (2018-2029)
1.6.1 North America Womens Health Market Size (2018-2029)
1.6.2 Europe Womens Health Market Size (2018-2029)
1.6.3 Asia-Pacific Womens Health Market Size (2018-2029)
1.6.4 Latin America Womens Health Market Size (2018-2029)
1.6.5 Middle East & Africa Womens Health Market Size (2018-2029)
2 Womens Health Market by Type
2.1 Introduction
2.1.1 Postmenopausal Osteoporosis
2.1.2 Endometriosis
2.1.3 Polycystic Ovary Syndrome
2.1.4 Infertility
2.1.5 Menopause
2.1.6 Others
2.2 Global Womens Health Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Womens Health Historic Market Size by Type (2018-2023)
2.2.2 Global Womens Health Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Womens Health Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Womens Health Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Womens Health Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Womens Health Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Womens Health Revenue Breakdown by Type (2018-2029)
3 Womens Health Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
3.2 Global Womens Health Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Womens Health Historic Market Size by Application (2018-2023)
3.2.2 Global Womens Health Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Womens Health Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Womens Health Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Womens Health Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Womens Health Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Womens Health Revenue Breakdown by Application (2018-2029)
4 Womens Health Competition Analysis by Players
4.1 Global Womens Health Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Womens Health as of 2022)
4.3 Date of Key Players Enter into Womens Health Market
4.4 Global Top Players Womens Health Headquarters and Area Served
4.5 Key Players Womens Health Product Solution and Service
4.6 Competitive Status
4.6.1 Womens Health Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business
5.1.3 Allergan Womens Health Products, Services and Solutions
5.1.4 Allergan Womens Health Revenue (US$ Million) & (2018-2023)
5.1.5 Allergan Recent Developments
5.2 Bayer
5.2.1 Bayer Profile
5.2.2 Bayer Main Business
5.2.3 Bayer Womens Health Products, Services and Solutions
5.2.4 Bayer Womens Health Revenue (US$ Million) & (2018-2023)
5.2.5 Bayer Recent Developments
5.3 Merck
5.3.1 Merck Profile
5.3.2 Merck Main Business
5.3.3 Merck Womens Health Products, Services and Solutions
5.3.4 Merck Womens Health Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Womens Health Products, Services and Solutions
5.4.4 Pfizer Womens Health Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Teva Pharmaceutical
5.5.1 Teva Pharmaceutical Profile
5.5.2 Teva Pharmaceutical Main Business
5.5.3 Teva Pharmaceutical Womens Health Products, Services and Solutions
5.5.4 Teva Pharmaceutical Womens Health Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Pharmaceutical Recent Developments
5.6 Agile Therapeutics
5.6.1 Agile Therapeutics Profile
5.6.2 Agile Therapeutics Main Business
5.6.3 Agile Therapeutics Womens Health Products, Services and Solutions
5.6.4 Agile Therapeutics Womens Health Revenue (US$ Million) & (2018-2023)
5.6.5 Agile Therapeutics Recent Developments
5.7 Amgen
5.7.1 Amgen Profile
5.7.2 Amgen Main Business
5.7.3 Amgen Womens Health Products, Services and Solutions
5.7.4 Amgen Womens Health Revenue (US$ Million) & (2018-2023)
5.7.5 Amgen Recent Developments
5.8 Apothecus Pharmaceutical
5.8.1 Apothecus Pharmaceutical Profile
5.8.2 Apothecus Pharmaceutical Main Business
5.8.3 Apothecus Pharmaceutical Womens Health Products, Services and Solutions
5.8.4 Apothecus Pharmaceutical Womens Health Revenue (US$ Million) & (2018-2023)
5.8.5 Apothecus Pharmaceutical Recent Developments
5.9 AstraZeneca
5.9.1 AstraZeneca Profile
5.9.2 AstraZeneca Main Business
5.9.3 AstraZeneca Womens Health Products, Services and Solutions
5.9.4 AstraZeneca Womens Health Revenue (US$ Million) & (2018-2023)
5.9.5 AstraZeneca Recent Developments
5.10 Blairex Laboratories
5.10.1 Blairex Laboratories Profile
5.10.2 Blairex Laboratories Main Business
5.10.3 Blairex Laboratories Womens Health Products, Services and Solutions
5.10.4 Blairex Laboratories Womens Health Revenue (US$ Million) & (2018-2023)
5.10.5 Blairex Laboratories Recent Developments
5.11 Bristol-Myers Squibb
5.11.1 Bristol-Myers Squibb Profile
5.11.2 Bristol-Myers Squibb Main Business
5.11.3 Bristol-Myers Squibb Womens Health Products, Services and Solutions
5.11.4 Bristol-Myers Squibb Womens Health Revenue (US$ Million) & (2018-2023)
5.11.5 Bristol-Myers Squibb Recent Developments
5.12 Ferring
5.12.1 Ferring Profile
5.12.2 Ferring Main Business
5.12.3 Ferring Womens Health Products, Services and Solutions
5.12.4 Ferring Womens Health Revenue (US$ Million) & (2018-2023)
5.12.5 Ferring Recent Developments
6 North America
6.1 North America Womens Health Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Womens Health Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Womens Health Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Womens Health Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Womens Health Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Womens Health Market Dynamics
11.1 Womens Health Industry Trends
11.2 Womens Health Market Drivers
11.3 Womens Health Market Challenges
11.4 Womens Health Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research